Cerebrolysin (Neurotrophic Peptide Preparation) – FPF 1070

Product Overview

Cerebrolysin is a highly sophisticated, biologically active mixture of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins via proprietary enzymatic proteolysis. Unlike single-molecule synthetic peptides, Cerebrolysin recapitulates the complex, multimodal action of endogenous neurotrophic factors (including NGF, BDNF, and GDNF). With over 50 years of clinical and investigative use, it is utilized in cutting-edge research to study the mechanisms of neuroprotection in ischemic environments, the promotion of synaptic plasticity, and the restoration of neuronal integrity in neurodegenerative models.

Technical Specifications

• Molecular Composition: Complex mixture (~85% free amino acids and ~15% low-molecular-weight neuropeptides <10 kDa)

• Molecular Weight: <10,000 Da (Peptide fraction)

• Biological Origin: Porcine brain-derived proteins (enzymatically processed)

• Sequence Profile: Multimodal mixture (mimics the action of NGF, BDNF, and GDNF)

Mechanism of Action

Cerebrolysin exerts its neuroprotective and neurorestorative effects through simultaneous, multimodal signaling pathways:

• Neurotrophic Factor Mimicry: Activates survival pathways by mimicking endogenous neurotrophic factors. It triggers PI3K/Akt signaling (inhibiting neuronal apoptosis) and modulates MAPK/ERK cascades to promote neuronal differentiation, axonal outgrowth, and neurite stabilization.

• Synaptic Plasticity Promotion: Enhances dendritic arborization, increases synaptic spine density, and promotes long-term potentiation (LTP)—the essential cellular substrate for learning, memory, and functional recovery.

• Excitotoxicity & Oxidative Stress Mitigation: Modulates glutamate receptor activity to reduce excitotoxic damage during ischemic events and provides direct antioxidant support against hydroxyl radical formation.

• Neurogenesis Stimulation: Actively stimulates adult neurogenesis in critical brain regions, specifically the hippocampal dentate gyrus and the subventricular zone, supporting the endogenous capacity for brain repair.

Primary Research Applications

Cerebrolysin is a premier compound for in vitro and animal model studies investigating:

• Acute Ischemic Stroke Neuroprotection and Penumbral Preservation

• Alzheimer’s Disease and Cognitive Decline Mechanisms

• Traumatic Brain Injury (TBI) Recovery and Functional Outcomes

• Neuroplasticity, Dendritic Branching, and Axonal Regeneration

• Vascular Dementia and Chronic Cerebrovascular Hypoperfusion

Storage & Handling

Store securely at room temperature (59°F to 77°F / 15°C to 25°C) and protect strictly from light. Do not freeze. Cerebrolysin is supplied as an aqueous solution; ensure sterility and maintain aseptic technique during all laboratory handling procedures.

⚠️ Important Disclaimer for Carbon Nova Labs Customers: All information provided is for educational and reference purposes only. Cerebrolysin is sold strictly for laboratory research use only. This compound is not approved by the FDA for human consumption, therapeutic use, or clinical application. Ensure compliance with all institutional safety protocols and consult qualified professionals before conducting research.